-
Sodium Citrate for 3D SERS Arrays
2026-08-23
Sodium citrate offers a practical way to tune ionic strength, pH, and metal–polymer interactions during citrate-conditioned gold nanoparticle assembly. This workflow translates a highly reproducible polymer pen lithography strategy into a controlled optimization plan for sensitive, uniform SERS substrates.
-
WZ4003 Lowers Tau Ser356 in Alzheimer’s Models
2026-08-22
Taylor et al. characterize tau phosphorylated at Ser356 as a pathology-associated species that accumulates with Alzheimer’s disease progression and localizes near synapses. Using mouse and human brain slice cultures, the study shows that pharmacological NUAK inhibition with WZ4003 lowers p-tau Ser356, while also revealing important differences between mouse and human ex vivo responses.
-
DiscoveryProbe Metabolism-related Compound Library Guide
2026-08-22
Build mechanism-first screens around metabolic enzymes, lipid regulators, and cell-based pathway responses with a ready-to-use small-molecule collection. The workflow connects biochemical screening to oxidative-stress and PPAR signaling readouts while emphasizing controls, orthogonal validation, and practical troubleshooting.
-
SC 79 Akt Activator: Workflow & Troubleshooting
2026-08-21
SC 79 is a cytosolic Akt activator for resolving how Akt phosphorylation affects neuronal survival, inflammatory aging, and stress responses. This practical guide combines assay design, washout experiments, pathway controls, and troubleshooting for more interpretable results.
-
Entecavir (BMS200475) for HBV Assays
2026-08-20
Build reproducible HBV replication assays with Entecavir, from DMSO stock preparation through resistance-aware readouts. This guide connects a potent polymerase inhibitor to practical wild-type, lamivudine-resistant, and longitudinal study designs.
-
MLN4924 HCl Salt: NAE Research Workflows
2026-08-20
MLN4924 HCl salt gives researchers a temporally controllable way to interrogate NAE-dependent cullin-RING ligase activity, protein turnover, cell-cycle control, and inflammatory cell death. This workflow connects pathway validation in cancer biology research with a reference-supported strategy for testing how viral proteins exploit host ubiquitination machinery.
-
Valemetostat and Dual EZH1/2 Inhibition in ATL
2026-08-19
The reference paper examines valemetostat, the first approved dual EZH1/2 inhibitor, and explains why simultaneous blockade of both PRC2 catalytic subunits is relevant to adult T-cell leukemia/lymphoma. Its clinical synthesis links the epigenetic mechanism to responses in relapsed or refractory disease while highlighting the need for larger controlled studies.
-
Recombinant Human FGF-19 Workflow Guide
2026-08-19
Build reproducible FGFR4 binding, proliferation, and metabolic signaling assays with a tag-free, lyophilized FGF-19 protein. This guide also shows how to use the sepsis-AKI WIP1/p38 MAPK study as a disciplined framework for exploratory cross-pathway experiments without overstating the evidence.
-
RIPA Lysis Buffer (Strong) for BBB Protein Studies
2026-08-18
RIPA Lysis Buffer (Strong) supports scalable protein extraction from brain tissues, astrocytes, and endothelial cultures for Western blotting, ELISA, and pathway-focused assays. Its strong detergent system improves recovery from difficult samples, while inhibitor supplementation and controlled handling help preserve inflammatory and tight-junction targets.
-
Puromycin Dihydrochloride: Practical Workflows
2026-08-18
Puromycin dihydrochloride combines fast, mechanism-defined selection with flexible perturbation of protein synthesis and ribosome behavior. This guide translates those properties into kill-curve, stable-line, translation-assay, and bladder cancer model workflows while separating established practice from exploratory applications.
-
MEG3, TGF-β, and NiO Nanoparticle Fibrosis
2026-08-17
The reference study identifies lncRNA MEG3 as a protective regulator in nickel oxide nanoparticle-induced pulmonary fibrosis, linking MEG3 suppression to TGF-β1-dependent PI3K/AKT activation and collagen deposition. Its combined rat, A549-cell, inhibitor, and MEG3-overexpression experiments provide a mechanistic framework for studying nanomaterial-induced lung injury, while also defining important limits for translation.
-
Nanoparticle Uptake in Human Corneal Epithelium
2026-08-17
Azadi and David systematically examined how PLGA nanoparticle size and surface chemistry influence uptake by human cornea epithelial cells. Their in vitro model links particle design to endocytic mechanisms, identifying macropinocytosis and caveolae-mediated endocytosis as dominant pathways and highlighting 100 nm PLGA and PEG-PLGA-150 particles as strong uptake candidates.
-
5X Protein Loading Buffer (Reducing) Guide
2026-08-16
5X Protein Loading Buffer (Reducing) prepares protein samples for conventional SDS-PAGE by combining SDS-mediated denaturation with disulfide-bond reduction and tracking-dye visualization. It is intended for reducing, denaturing workflows and should not be used when native conformation or non-reducing protein structure must be preserved.
-
GSK2606414 in PERK-Driven Metabolic Stress
2026-08-15
GSK2606414 is a potent PERK inhibitor for dissecting how ER stress becomes metabolic liver injury. This article translates recent TMAO–NAFLD findings into a causal assay strategy while defining controls, readouts, and interpretation limits.
-
4-Phenylbutyric acid in ER-Stress Assays
2026-08-14
Discover how 4-Phenylbutyric acid and 4-PBA can transform PFOS kidney-toxicity studies from descriptive ER-stress assays into causal experiments. This guide connects chemical-chaperone biology, ferroptosis readouts, and reproducible HK-2 cell assay design.